The diagnosis of prostate cancer is based on clinical (rectal touch), laboratory (prostate-specific antigen [PSA]) and radiological (ultrasound and computed tomography) exams, which may indicate the need for a transrectal biopsy. This evidence concerns the gene KLK3 and Familial prostate cancer.